Together, these findings suggest that high SSTR2 expression is associated with a molecular profile enriched for pro-tumorigenic and pro-metastatic signaling pathways, reinforcing its potential role as a functional driver of HCC progression. The gene discussed is SSTR2; the disease is hepatocellular carcinoma.